+51.8%
XBIO price history and return analytics
+23.3%
+28.5%
-80.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.9% | 0.0% | +0.9% | +0.9% |
| 7D | +17.3% | +0.4% | +16.9% | +16.5% |
| 30D | +57.8% | +1.0% | +56.8% | +55.5% |
| 3M | +36.2% | +2.4% | +33.8% | +31.8% |
| 6M | +93.0% | +12.0% | +81.0% | +64.0% |
| YTD | +115.2% | +15.3% | +99.9% | +59.7% |
| 1Y | +51.8% | +22.6% | +29.2% | +27.9% |
| All | +51.8% | +23.3% | +28.5% | +27.9% |
Cumulative growth
Daily Returns
Daily percentage return beside VT.
Daily Out/Under-Performance
Portfolio return minus VT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling